ALHAMBRA, Calif., Dec. 18, 2023 /PRNewswire/ -- Apollo Medical
Holdings, Inc. ("ApolloMed," and together with its subsidiaries and
affiliated entities, the "Company") (NASDAQ: AMEH), a leading
physician-centric, technology-powered healthcare company focused on
enabling providers in the successful delivery of value-based care,
today announced that effective on December
15, 2023, the Compensation Committee of ApolloMed's Board of
Directors (the "Committee") granted a total of 38,779 shares of
restricted common stock to eight newly-hired non-executive
employees, under the Apollo Medical Holdings, Inc. Employment
Inducement Award Plan (the "Inducement Plan"). The Inducement Plan
is used exclusively for the grant of equity awards to individuals
who were not previously an employee or non-employee director of the
Company (or following a bona fide period of non-employment) as an
inducement material to such individuals' commencement of employment
with the Company, in accordance with Nasdaq Listing Rule
5635(c)(4).
Of the restricted stock granted, 22,182 shares will vest,
subject to continued employment, over four years in substantially
equal annual installments on the first, second, third and fourth
anniversaries of the grant date, and 16,597 shares will vest,
subject to continued employment, based on the achievement of the
applicable performance targets and the same time-based vesting
conditions as the other shares of restricted stock granted. The
restricted stock is subject to the terms and conditions of the
Inducement Plan and an award agreement covering each grant.
About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered,
risk-bearing healthcare company. Leveraging its proprietary
end-to-end technology solutions, ApolloMed operates an integrated
healthcare delivery platform that enables providers to successfully
participate in value-based care arrangements, thus empowering them
to deliver outcomes-based medical care to patients in a
cost-effective manner.
Headquartered in Alhambra,
California, ApolloMed's subsidiaries and affiliates include
management services organizations (MSOs), affiliated independent
practice associations (IPAs), and entities participating in the
Centers for Medicare & Medicaid Services Innovation Center
(CMMI) innovation models. For more information, please visit
www.apollomed.net.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@apollomed.net
Asher Dewhurst, ICR Westwicke
ApolloMedIR@westwicke.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-announces-grant-of-inducement-awards-pursuant-to-nasdaq-listing-rule-5635c4-302018194.html
SOURCE Apollo Medical Holdings, Inc.
